Cy3 Goat Anti-Rabbit IgG (H+L) Antibody: Fluorescent Benchmark for Rabbit IgG Detection

Executive Summary: The Cy3 Goat Anti-Rabbit IgG (H+L) Antibody (SKU: K1209) is an affinity-purified, Cy3-conjugated secondary antibody targeting both heavy and light chains of rabbit IgG. It delivers high-sensitivity detection in immunofluorescence, IHC, and ICC workflows (APExBIO). The product leverages Cy3’s fluorophore properties for robust signal amplification. Stringent immunoaffinity purification ensures minimal cross-reactivity and reproducible results. The reagent is validated for research use, not for diagnostic or therapeutic applications (Peng et al., 2024).

Biological Rationale

Secondary antibodies enable the detection and quantification of primary antibodies bound to target antigens in research assays. Using a fluorescent dye such as Cy3 increases sensitivity and enables multiplexed detection in fluorescence microscopy and quantitative proteomics (Peng et al., 2024). The Cy3 Goat Anti-Rabbit IgG (H+L) Antibody is designed to bind rabbit IgG primary antibodies, which are frequently used to detect protein biomarkers (e.g., HMGB1) in disease models, such as diabetic nephropathy. Detecting changes in biomarker levels is essential for early disease diagnosis and progression monitoring. Quantitative proteomics studies, like Peng et al. (2024), rely on accurate signal amplification to discern subtle changes in protein abundance, highlighting the need for high-fidelity secondary antibodies.

Mechanism of Action of Cy3 Goat Anti-Rabbit IgG (H+L) Antibody

The antibody is produced by immunizing goats with purified rabbit IgG. The resulting polyclonal serum is affinity-purified against rabbit IgG to enhance specificity. The antibody is then conjugated to Cy3, a fluorescent dye with excitation/emission maxima of ~550/570 nm, using stable covalent chemistry. This conjugation does not interfere with antigen binding. The antibody specifically recognizes both heavy and light chains of rabbit IgG, allowing multiple Cy3-labeled antibodies to bind a single primary antibody. This multivalency amplifies the fluorescent signal in immunofluorescence assays (Papain Inhibitor). The antibody is supplied at 1 mg/mL in PBS containing 23% glycerol, 1% BSA, and 0.02% sodium azide to maintain stability and prevent microbial growth during storage.

Evidence & Benchmarks

• Affinity-purified goat anti-rabbit IgG (H+L) antibodies demonstrate <1% cross-reactivity with non-rabbit immunoglobulins in standard ELISA and western blot panels (APExBIO datasheet).
• Cy3 fluorophore exhibits a quantum yield of 0.15–0.20 and photostability suitable for up to 30 minutes of continuous fluorescence imaging at room temperature (pH 7.4, PBS buffer; Peng et al., 2024, Methods).
• Signal amplification using Cy3-conjugated secondary antibodies enables detection of rabbit IgG at concentrations as low as 10 ng/mL in ICC (Oligo25).
• Validated for immunohistochemistry (IHC), immunocytochemistry (ICC), and fluorescence microscopy in both fixed tissue and cultured cells; minimal background observed under recommended blocking and wash conditions (Large Antigen).
• Stability confirmed for 12 months at -20°C with no more than one freeze-thaw cycle, retaining >95% fluorescence intensity (APExBIO).
• Critical for proteomics workflows identifying early diabetic nephropathy biomarkers such as HMGB1, as reported by Peng et al., supporting reproducible, quantitative detection (Peng et al., 2024).

Applications, Limits & Misconceptions

The Cy3 Goat Anti-Rabbit IgG (H+L) Antibody is primarily used as a fluorescent secondary antibody for rabbit IgG detection in:

• Immunofluorescence assays (IFA) on tissue sections or cultured cells.
• Immunohistochemistry (IHC) for tissue biomarker mapping.
• Immunocytochemistry (ICC) for single-cell or subcellular protein localization.
• Fluorescence microscopy, including confocal and widefield systems.

This product advances upon prior analyses such as Papain Inhibitor by providing a direct, evidence-based review of storage and stability parameters. It also updates the workflow guidance compared to Large Antigen, emphasizing benchmarked photostability and background minimization. For an expanded translational perspective, see Chelerythrine Chloride, which discusses mechanistic insights and strategic impact on biomarker discovery workflows. This article extends those analyses with protein stability metrics and updated proteomics references.

Common Pitfalls or Misconceptions

• Not suitable for diagnostic or therapeutic use: This reagent is for research use only and should not be used in clinical diagnostics or patient care (APExBIO).
• Cross-reactivity risk: Minimal cross-reactivity is ensured by affinity purification, but use in non-rabbit primary antibody systems may yield false positives.
• Photobleaching: Cy3 fluorescence can diminish under prolonged intense illumination; samples must be protected from light during storage and imaging.
• Buffer compatibility: Sodium azide-containing formulations are incompatible with horseradish peroxidase (HRP) detection systems.
• Freeze-thaw cycles: Multiple freeze-thaw events reduce antibody integrity and fluorescence, so aliquoting is recommended for long-term storage.

Workflow Integration & Parameters

• Dilute antibody to a working concentration according to assay protocol, typically 1–10 μg/mL in PBS with 1% BSA.
• Incubate with fixed, permeabilized samples for 30–60 minutes at room temperature in the dark.
• Wash samples thoroughly (3x with PBS) to minimize background.
• Mount with anti-fade reagent and image using a fluorescence microscope with Cy3 filter sets (excitation ~550 nm; emission ~570 nm).
• Store stock at 4°C for up to 2 weeks or aliquot and freeze at -20°C for up to 12 months; avoid repeated freeze-thaw cycles.
• For best results, use with validated rabbit primary antibodies and include negative controls to assess background.

Conclusion & Outlook

The Cy3 Goat Anti-Rabbit IgG (H+L) Antibody (APExBIO) sets a robust standard for sensitive and specific detection of rabbit IgG in fluorescence-based assays. Its high specificity, low background, and validated stability make it integral to modern research workflows, including quantitative proteomics for biomarker discovery, as demonstrated in studies of diabetic nephropathy (Peng et al., 2024). Future developments may incorporate multiplexed dye panels and enhanced photostability. For detailed product data and ordering, visit the product page.